155 related articles for article (PubMed ID: 16594544)
1. Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and synovial fluid of osteoarthritic dogs.
Salinardi BJ; Roush JK; Schermerhorn T; Mitchell KE
Vet Comp Orthop Traumatol; 2006; 19(1):49-55. PubMed ID: 16594544
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
3. Effects of moving training on histology and biomarkers levels of articular cartilage.
Qi C; Changlin H
J Surg Res; 2006 Oct; 135(2):352-63. PubMed ID: 16904690
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for identifying the early phases of osteoarthritis secondary to medial patellar luxation in dogs.
Alam MR; Ji JR; Kim MS; Kim NS
J Vet Sci; 2011 Sep; 12(3):273-80. PubMed ID: 21897101
[TBL] [Abstract][Full Text] [Related]
6. Deposition of fibronectin in articular cartilage of canine osteoarthritic joints.
Burton-Wurster N; Lust G
Am J Vet Res; 1985 Dec; 46(12):2542-5. PubMed ID: 4083590
[TBL] [Abstract][Full Text] [Related]
7. Correlation of serum and synovial leptin concentrations with body condition scores in healthy and osteoarthritic dogs.
Kleine SA; Sanderson SL; George C; Roth I; Gogal RM; Thaliath MA; Budsberg SC
Vet Surg; 2019 Jul; 48(5):780-785. PubMed ID: 31155740
[TBL] [Abstract][Full Text] [Related]
8. Gelatinase activity in synovial fluid and synovium obtained from healthy and osteoarthritic joints of dogs.
Volk SW; Kapatkin AS; Haskins ME; Walton RM; D'Angelo M
Am J Vet Res; 2003 Oct; 64(10):1225-33. PubMed ID: 14596458
[TBL] [Abstract][Full Text] [Related]
9. Synovial MMP-3 and TIMP-1 levels and their correlation with cytokine expression in canine rheumatoid arthritis.
Hegemann N; Wondimu A; Ullrich K; Schmidt MF
Vet Immunol Immunopathol; 2003 Feb; 91(3-4):199-204. PubMed ID: 12586482
[TBL] [Abstract][Full Text] [Related]
10. Degeneration of normal articular cartilage induced by late phase osteoarthritic synovial fluid in beagle dogs.
Xu QR; Dong YH; Chen SL; Bao CD; Du H
Tissue Cell; 2009 Feb; 41(1):13-22. PubMed ID: 18692211
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of matrix metalloproteinase-9/tissue inhibitors of matrix metalloproteinase -1 imbalance in maternal serum, amniotic fluid, umbilical cord serum in patients with premature rupture of the membranes].
Lu D; Wang ZX; Wang XL; Gu XW; Wang YX; Fu D
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):20-4. PubMed ID: 16635322
[TBL] [Abstract][Full Text] [Related]
12. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone.
Hulejová H; Baresová V; Klézl Z; Polanská M; Adam M; Senolt L
Cytokine; 2007 Jun; 38(3):151-6. PubMed ID: 17689092
[TBL] [Abstract][Full Text] [Related]
13. Examination of synovial fluid hyaluronan quantity and quality in stifle joints of dogs with osteoarthritis.
Venable RO; Stoker AM; Cook CR; Cockrell MK; Cook JL
Am J Vet Res; 2008 Dec; 69(12):1569-73. PubMed ID: 19046002
[TBL] [Abstract][Full Text] [Related]
14. The effect of intra-articular botulinum toxin A on substance P, prostaglandin E
Heikkilä HM; Hielm-Björkman AK; Innes JF; Laitinen-Vapaavuori OM
BMC Vet Res; 2017 Mar; 13(1):74. PubMed ID: 28327134
[TBL] [Abstract][Full Text] [Related]
15. Serum and synovial fluid concentrations of keratan sulfate and hyaluronan in dogs with induced stifle joint osteoarthritis following cranial cruciate ligament transection.
Budsberg SC; Lenz ME; Thonar EJ
Am J Vet Res; 2006 Mar; 67(3):429-32. PubMed ID: 16506904
[TBL] [Abstract][Full Text] [Related]
16. Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays.
Fietz S; Einspanier R; Hoppner S; Hertsch B; Bondzio A
Equine Vet J; 2008 May; 40(3):266-71. PubMed ID: 18089467
[TBL] [Abstract][Full Text] [Related]
17. Nerve growth factor concentrations in the synovial fluid from healthy dogs and dogs with secondary osteoarthritis.
Isola M; Ferrari V; Miolo A; Stabile F; Bernardini D; Carnier P; Busetto R
Vet Comp Orthop Traumatol; 2011; 24(4):279-84. PubMed ID: 21674121
[TBL] [Abstract][Full Text] [Related]
18. Correlation between synovial fluid cytokine concentrations and limb function in normal dogs and in dogs with lameness from spontaneous osteoarthritis.
Allen PI; Conzemius MG; Evans RB; Kiefer K
Vet Surg; 2019 Jul; 48(5):770-779. PubMed ID: 31032990
[TBL] [Abstract][Full Text] [Related]
19. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.
Tchetverikov I; Lohmander LS; Verzijl N; Huizinga TW; TeKoppele JM; Hanemaaijer R; DeGroot J
Ann Rheum Dis; 2005 May; 64(5):694-8. PubMed ID: 15834054
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of normal and osteoarthritic canine synovial fluid using 500 MHz 1H magnetic resonance spectroscopy.
Damyanovich AZ; Staples JR; Chan AD; Marshall KW
J Orthop Res; 1999 Mar; 17(2):223-31. PubMed ID: 10221839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
